Certified by Founder Lodge
ArrePath
United States - Princeton, New Jersey
START UP
1 Disclosed Funding Rounds $20,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the ar
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 03 ,2022 | Seed | $20,000,000 |
PTX Capital
Innospark Ventures
Viva BioInnovator
Nor'easter Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Mondra | $13,206,500 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
